• New rapid antibiotics test from Fraunhofer and partners / 2019

    Better treatment for diabetic foot ulcers

    Research News / October 01, 2019

    People with type 2 diabetes often suffer from poorly-healing infected wounds on their feet. Using existing methods, however, it takes two days to grow a bacterial culture used to identify the pathogens infecting the wound and their antibiotic resistance – and thus to find an effective antibiotic. With the help of a new rapid test developed by Fraunhofer researchers, it will take just one hour to obtain this information in the future.

    more info
  • Alga of the year 2019

    Joint press release of the Phycology Section in the German Society for Plant Sciences (DBG) and the Fraunhofer IZI-BB / January 07, 2019

    Die leuchtend roten Schneefelder, die die Blutschneealgen enthalten, erstrecken sich über weite Flächen, wie hier auf dem Doktorbreen-Gletscher in Spitzbergen im August 2004.
    © Fraunhofer IZI-BB, Foto: Thomas Leya

    Worldwide the alga Chlamydomonas nivalis is known for turning snow pink and was now chosen as alga of the year 2019. 200 Years have passed since captain John Ross made his first Arctic expedition, where he charted the peculiar pink snow and tried to identify the reason for the coloring under the microscope. The snow alga and its life cycle remain mysterious ever since. Dr. Thomas Leya from the Fraunhofer IZI-BB, an expert on snow algae, explains the phenomenon and where to find such algae. Leya is a member of the Phycology Section in the German Society for Plant Sciences (DBG) that chose Chlamydomonas nivalis as alga of the year 2019.

    more info
  • European Commission supports »DigiTwins«

    Press releases / May 18, 2018

    © DigiTwins

    Today, 18th of May, DigiTwins received an invitation from the European Commission to enter the next stage of the competition to become an EU Flagship for Future and Emerging Technologies. DigiTwins, a large research initiative in Europe and beyond aims at revolutionizing healthcare and biomedical research for the benefit of citizens and society and at contributing to Europe’s Digital Single Market strategy through the creation of Digital Twins.

    more info